This page lists the SEC filings reported by KINGSBROOK PARTNERS LP.
| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G/A | 2021-02-05 | KINGSBROOK PARTNERS LP | ARTELO BIOSCIENCES, INC. | 800,000 | 5.0% | EDGAR |
| SC 13G | 2020-10-15 | KINGSBROOK PARTNERS LP | ARTELO BIOSCIENCES, INC. | 800,000 | 5.8% | EDGAR |
| SC 13G/A | 2016-02-16 | KINGSBROOK PARTNERS LP | MYOS Corp | 160,086 | 4.4% | EDGAR |
| SC 13G | 2015-12-02 | KINGSBROOK PARTNERS LP | MYOS Corp | 225,912 | 6.4% | EDGAR |
| SC 13G/A | 2015-02-13 | KINGSBROOK PARTNERS LP | CorMedix Inc. | 61,598 | 4.9% | EDGAR |
| SC 13G | 2014-03-05 | KINGSBROOK PARTNERS LP | CorMedix Inc. | 1,480,000 | 6.8% | EDGAR |
| SC 13G/A | 2013-02-14 | KINGSBROOK PARTNERS LP | ONCOSEC MEDICAL Inc | - | 3.0% | EDGAR |
| SC 13G/A | 2013-02-14 | KINGSBROOK PARTNERS LP | NovaBay Pharmaceuticals, Inc. | 25,000 | 2.9% | EDGAR |
| SC 13G | 2012-03-29 | KINGSBROOK PARTNERS LP | ONCOSEC MEDICAL Inc | 5,300,000 | 6.0% | EDGAR |
| SC 13G | 2012-02-22 | KINGSBROOK PARTNERS LP | Apps Genius Corp | 1,613,362 | 4.9% | EDGAR |
| SC 13G/A | 2012-02-13 | KINGSBROOK PARTNERS LP | RADIENT PHARMACEUTICALS Corp | 144,201 | 1.0% | EDGAR |
| SC 13G/A | 2012-02-13 | KINGSBROOK PARTNERS LP | NovaBay Pharmaceuticals, Inc. | 2,272,551 | 9.9% | EDGAR |
| SC 13G | 2011-07-08 | KINGSBROOK PARTNERS LP | RADIENT PHARMACEUTICALS Corp | 235,159 | 9.9% | EDGAR |
| SC 13G | 2011-07-05 | KINGSBROOK PARTNERS LP | NovaBay Pharmaceuticals, Inc. | 2,800,000 | 9.9% | EDGAR |
- Form 13F-HR
- The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
- Form SC 13D/G
- Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
- Form 3, 4, and 5
- Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.